FDA approves Primatene Mist
The FDA approved Primatene Mist last week for over-the-counter (OTC) status. It was taken off the market in 2011 because of its CFC propellants, which have been shown to damage the ozone layer. It is now being reintroduced with an ozone-safe HFA propellant, the same one used in all prescription metered-dose inhalers for asthma and COPD. Dr. Steven shares the concerns about this development that have been expressed by the President of the ACAAI, Dr. Bradley Chipps. Not only does the medication in Primatene Mist have more potential side effects than the asthma rescue medications available by prescription, but allergists should be involved in supervising the...
Posted on November 12, 2018 Read more...

FDA alerts patients with EpiPens
From the FDA: FDA is alerting patients, caregivers and health care professionals that the labels attached to some EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, and the authorized generic versions, may block access to the auto-injector and prevent the ability to easily access the product. In a letter to health care professionals from Pfizer, the manufacturer of the Mylan EpiPen, the label sticker on the auto-injector unit may have been improperly applied, causing resistance when removing it from the carrier tube. The carrier tube is the immediate package in which the auto-injector is contained. In some cases, the patient or caregiver may not be able to quickly remove...
Posted on November 7, 2018 Read more...

The above posts and many other topics can be viewed on our News Page
Allergy Shot Hours Today
Greenfield Office: 08:30AM to 12:30PM
Click here for the full calendar
Milwaukee Pollen Counts
Pollen and mold counts have concluded for this year. Check back next spring for new counts.

Location Information
The Allergy, Asthma & Sinus Center has three conveniently located clinics to serve you better. Click here for maps, directions and hours.
What our patients are saying